BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 10734307)

  • 1. Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease.
    Epstein JB; Nantel S; Sheoltch SM
    Bone Marrow Transplant; 2000 Mar; 25(6):683-7. PubMed ID: 10734307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical cyclosporin A for treatment of oral chronic graft-versus-host disease.
    Epstein JB; Reece DE
    Bone Marrow Transplant; 1994 Jan; 13(1):81-6. PubMed ID: 8019458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gran versus host disease with oral involvement: report of one case].
    Rojas A G; González G N; Venables G C; Araos H D
    Rev Med Chil; 2008 Dec; 136(12):1570-3. PubMed ID: 19350175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases.
    Epstein JB; Gorsky M; Epstein MS; Nantel S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jan; 91(1):56-61. PubMed ID: 11174572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.
    Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B
    Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budesonide for local therapy of complex oral mucosal immune-mediated inflammatory diseases: case reports.
    Utsman RA; Epstein JB; Elad S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul; 106(1):e11-7. PubMed ID: 18585605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic graft versus host disease of oral mucosa: review of available therapies.
    Imanguli MM; Pavletic SZ; Guadagnini JP; Brahim JS; Atkinson JC
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):175-83. PubMed ID: 16448918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment].
    Elad S; Levitt M; M Y S
    Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):19-27, 72. PubMed ID: 19263864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral graft-versus-host disease.
    Schubert MM; Correa ME
    Dent Clin North Am; 2008 Jan; 52(1):79-109, viii-ix. PubMed ID: 18154866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral graft vs. host disease in children--treatment with topical tacrolimus ointment.
    Albert MH; Becker B; Schuster FR; Klein B; Binder V; Adam K; Nienhoff C; Führer M; Borkhardt A
    Pediatr Transplant; 2007 May; 11(3):306-11. PubMed ID: 17430488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budesonide: a novel treatment for oral chronic graft versus host disease.
    Elad S; Or R; Garfunkel AA; Shapira MY
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Mar; 95(3):308-11. PubMed ID: 12627101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease.
    Fricain JC; Sibaud V; Swetyenga N; Tabrizi R; Campana F; Taïeb A
    Br J Dermatol; 2007 Mar; 156(3):588-90. PubMed ID: 17300261
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of oral lichen planus-like chronic graft-versus-host disease with topical tacrolimus: a case report.
    Sánchez AR; Sheridan PJ; Rogers RS
    J Periodontol; 2004 Apr; 75(4):613-9. PubMed ID: 15152828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of budesonide mouthwash on oral chronic graft versus host disease.
    Sari I; Altuntas F; Kocyigit I; Sisman Y; Eser B; Unal A; Fen T; Ferahbas A; Ozturk A; Unal A; Cetin M
    Am J Hematol; 2007 May; 82(5):349-56. PubMed ID: 17109390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral graft-versus-host disease: successful therapy with extracorporeal photopheresis and topical tacrolimus.
    Schlaak M; Treudler R; Colsman A; Al-Ali H; Simon JC
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):112-3. PubMed ID: 18181987
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of topical cyclosporin A in ocular graft-versus-host-disease.
    Kiang E; Tesavibul N; Yee R; Kellaway J; Przepiorka D
    Bone Marrow Transplant; 1998 Jul; 22(2):147-51. PubMed ID: 9707022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs.-host disease.
    Wolff D; Anders V; Corio R; Horn T; Morison WL; Farmer E; Vogelsang GB
    Photodermatol Photoimmunol Photomed; 2004 Aug; 20(4):184-90. PubMed ID: 15238096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical cyclosporine in a bioadhesive for treatment of oral lichenoid mucosal reactions: an open label clinical trial.
    Epstein JB; Truelove EL
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Nov; 82(5):532-6. PubMed ID: 8936517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamous cell carcinoma of the oral cavity associated with graft versus host disease: report of a case and review of the literature.
    Demarosi F; Soligo D; Lodi G; Moneghini L; Sardella A; Carrassi A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jul; 100(1):63-9. PubMed ID: 15953918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary gland involvement in graft-versus-host disease: the underlying mechanism and implicated treatment.
    Nagler RM; Nagler A
    Isr Med Assoc J; 2004 Mar; 6(3):167-72. PubMed ID: 15055275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.